Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer

Clinical Cancer Research

Volumn 23, Issue 8, 2017, Pages 2061-2070

  Liang, Qiaoyi ^a   Chiu, Jonathan ^a   Chen, Yingxuan ^b   Huang, Yanqin ^c   Higashimori, Akira ^a,d   Fang, Jingyuan ^b   Brim, Hassan ^e   Ashktorab, Hassan ^e   Chien Ng, Siew ^a   Ng, Simon Siu Man ^f   Zheng, Shu ^b   Chan, Francis Ka Leung ^a   Sung, Joseph Jao Yiu ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e HOWARD UNIVERSITY CANCER CENTER   (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASIAN; BACTEROIDES; BACTEROIDES CLARUS; CANCER DIAGNOSIS; CLOSTRIDIUM HATHEWAYI; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FECES MICROFLORA; FEMALE; FUSOBACTERIUM NUCLEATUM; HUMAN; MAJOR CLINICAL STUDY; MALE; METAGENOME; NON INVASIVE PROCEDURE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; ROSEBURIA INTESTINALIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; COLORECTAL NEOPLASMS; FECES; INTESTINE FLORA; MICROBIOLOGY; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 85018799210     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-16-1599     Document Type: Article

References (31)

1. Sung JJ, Lau JY,GohKL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005;6:871-6.
2. Irrazabal T, Belcheva A,Girardin SE,Martin A, PhilpottDJ. The multifaceted role of the intestinal microbiota in colon cancer.MolCell 2014;54:309-20.
3. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013; 105:1907-11.
4. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33.
5. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacteriumnucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
6. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. Ametagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.
7. Shin NR, Lee JC, LeeHY,KimMS,Whon TW, LeeMS, et al.Anincrease in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014;63:727-35.
8. McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One 2013;8: e53653.
9. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207-15.
10. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/ beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013; 14:195-206.
11. Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 2015;6:8727.
12. Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 2015 Sep 25. [Epub ahead of print].
13. Jalanka J, Salonen A, Salojarvi J, Ritari J, Immonen O, Marciani L, et al. Effects of bowel cleansing on the intestinal microbiota. Gut 2015;64: 1562-8.
14. Wang Y, Qian PY. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 2009;4:e7401.
15. Huang Y, Li Q, Ge W, Cai S, Zhang S, Zheng S. Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm. Eur J Cancer Prev 2014;23:27-34.
16. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
17. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
18. Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015;64:121-32.
19. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014;160:171.
20. Flanagan L, Schmid J, Ebert M, Soucek P, Kunicka T, Liska V, et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 2014;33:1381-90.
21. Suzuki MT, Taylor LT, DeLong EF. Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 50-nuclease assays. Appl Environ Microbiol 2000;66:4605-14.
22. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002;148:257-66.
23. Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set andminor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 2004;42:2566-72.
24. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80.
25. Suehiro Y, Sakai K, Nishioka M, Hashimoto S, Takami T, Higaki S, et al. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population. Ann Clin Biochem. 2016 Apr 28. [Epub ahead of print].
26. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell 2014;159:789-99.
27. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-8.
28. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 2014;588:4223-33.
29. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.
30. Watanabe Y, Nagai F, MorotomiM, Sakon H, Tanaka R. Bacteroides clarus sp. nov., Bacteroides fluxus sp. nov. and Bacteroides oleiciplenus sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2010;60:1864-9.
31. Steer T, Collins MD, Gibson GR, Hippe H, Lawson PA. Clostridium hathewayi sp. nov., from human faeces. Syst Appl Microbiol 2001; 24:353-7.